Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Myeloma
100%
Cell Response
100%
NKp44
100%
Proliferating Cell nuclear Antigen
100%
Natural Killer Cells
100%
Antibody-antigen
30%
Tumor Cells
20%
Immunotherapeutics
20%
Overall Survival
10%
New Therapies
10%
Innate Immune Response
10%
Novel Pathways
10%
Anti-tumor Response
10%
Incurable Disease
10%
Disease Therapy
10%
Myeloma
10%
Early Disease
10%
Antibody-mediated
10%
Tumor
10%
Multiple Myeloma Patients
10%
Clinical Trials
10%
Normal White Blood Cells
10%
Immunology and Microbiology
Natural Killer Cell Response
100%
Multiple Myeloma
100%
Cycline
100%
Natural Killer Cell
30%
Immune Complex
30%
Immunomodulating Drugs
20%
Tumor Cell
20%
Innate Immune System
10%
Leukocyte
10%
Overall Survival
10%
Natural Cytotoxicity Triggering Receptor 2
10%